Paul Breillat/LinkedIn
Jul 8, 2026, 19:25
Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research
Paul Breillat, Assistant Clinical Fellow in Internal Medicine and Clinical Immunology at Cochin Hospital, shared a post on LinkedIn about a recent article by Holly Webster, published in Nature Reviews Rheumatology, adding:
“Happy to see that our latest article on monocyte dysfunction and inflammatory cell death in VEXAS syndrome has been highlighted by Nature Reviews Rheumatology!
Many thanks to all the collaborators and co-authors who made this work possible.”
Title: Dysfunctional UBA1-mutated myeloid cells promote inflammation in VEXAS syndrome
Authors: Holly Webster
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 10:10Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children
-
Aug 23, 2026, 16:02Bartosz Hudzik: What’s Hot at ESC Congress 2026
-
Aug 23, 2026, 16:01Jim Hoffman: NETs in STEMI and Their Association With PCI and Antithrombotic Treatments
-
Aug 23, 2026, 16:01Luis Oliverio Ambriz Garcia: Key Insights Into Myeloproliferative Neoplasms From the 2026 NEJM Review